pubrio
ALAR Pharmaceuticals Inc. logo

ALAR Pharmaceuticals Inc.

Public
alarpharm.com
制药行业9 employeesFounded 2016🇹🇼 台湾

Alar Pharmaceuticals Inc. (abbreviated as Alar), a new drug development company, was established in 2016. We focus on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder.

成立年份
2016
员工人数
9
行业
制药行业
公司类型
Public Company
股票
two: 6785.TWO
总部
🇹🇼Keya Rd., Daya Dist., 5f., No. 32, Taichung City, 428015, Tw (+1)
专长
制药行业生物技术医疗保健

扩张情报

全新 · 仅在 Pubrio

我们正在追踪 ALAR Pharmaceuticals Inc. 的市场扩张

全球扩张

实时
阶段
探索中投入中进入中运营中
了解一下

关于 ALAR Pharmaceuticals Inc. 的常见问题

关于 ALAR Pharmaceuticals Inc. 的业务、市场和增长信号的快速解答。

Alar Pharmaceuticals Inc. (abbreviated as Alar), a new drug development company, was established in 2016. We focus on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。